Researchers evaluated the potential clinical impact and cost-effectiveness of administering long-acting, injectable ...

编者按：从每日口服数十片药物到单片复合制剂的普及，HIV治疗历经数次革命性跨越。近年来，长效注射疗法的崛起正推动治疗模式向“超长间隔”迈进——HIV感染者有望从每日口服转向每月甚至每半年一次的给药，有效减轻病耻感与用药负担。在2025年反转录病毒和机 ...

HIV infections are lifelong and can weaken the immune system, causing a patient to be more susceptible to infection and ...

编者按：尽管抗逆反录病毒治疗（ART）极大改善了HIV感染者的生存质量，但终身服药的负担与病毒储藏库问题仍是HIV治疗方面所面临的重要挑战。近年来，基因编辑技术与免疫疗法的突破为HIV功能性治愈带来了新希望。在2025年反转录病毒和机会性感染大会（C ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

Groundbreaking HIV cure study in South Africa shows the safety and potential efficacy of a novel therapeutic regimen in women ...

Taimed Biologics Inc.’s TMB-365/TMB-380 long-acting combination of broadly neutralizing antibodies (bnAbs) regimen for HIV maintenance could reshape HIV treatment management, offering a viable ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...